NEW YORK--(BUSINESS WIRE)--Enfusion, a best-in-class software-as-a-service (SaaS) platform for investment managers, today announced the completion of the second phase of a strategic investment management platform migration by Kayne Anderson. Kayne Anderson is a leading alternative investment management firm focused on real estate, infrastructure, energy, credit, and growth capital. The first phase focused on Order and Execution Management and successfully concluded following a three-month disruption-free deployment. The second phase further consolidated Kayne Anderson’s front and back office onto a single platform with the implementation of Enfusion’s accounting module in under seven months. By consolidating previously disparate on-premise systems onto a single SaaS platform, Kayne Anderson has realized workflow optimizations across front-, middle-, and back-office functions. Improved order workflows have led to enhanced productivity and operational efficiency

SteelEye and Enfusion have established a partnership to offer joint clients a seamless experience, with trade and order data from Enfusion’s investment management solutions flowing automatically into SteelEye’s integrated compliance platform.Traditionally, the implementation of trade-based compliance systems for surveillance, reporting, and best execution is lengthy and complex. The partnership between SteelEye and Enfusion takes the legwork out of implementing these systems and makes the process seamless. As a result, the onboarding of SteelEye is speedy with minimal effort from investment managers.This was a key driver for Alken Asset Management selecting SteelEye and Enfusion.“As we were diversifying our internal trading and compliance systems, we were looking for tools that would make the migration smooth and easy – and this is what we received with SteelEye and Enfusion. In fact, Alken Asset Management’s data was flowing from Enfusion into SteelEye’s UAT environment before we had even initiated the onboarding kick-off call,” said Divesh Patel – Operations Manager at Alken Asset Management.“We decided to join forces with Enfusion to deliver additional value to our joint clients. The technical partnership goes a long way to address the pains of onboarding trading and compliance systems. In addition, joint clients get seamless access to SteelEye’s Integrated Surveillance tools which include archiving and communications monitoring – enabling them to do more with less,” added Matt Smith, CEO of SteelEye.Also commenting on the announcement, Peter Salvage, Managing Director, Global Head of Channel & Alliance Partnerships at Enfusion, said: “We are delighted that Alken Asset Management selected Enfusion and SteelEye

Technology and regulation have moved on since the last global recession, giving investors better tools to navigate what looks likely to be a year of extreme uncertainty – one in which none of the old rules about economic performance seem to apply. We asked two leading providers to the market – Christian Kahl PhD, President of FINCAD, the capital markets division of Zafin, and Gennadiy Friedman, MD of Enfusion – for their analysisTHE FINTECH MAGAZINE: How do market conditions today compare with the financial crisis of 2008 and how have changes since then shaped the current environment for hedge funds?GENNADIY FRIEDMAN: After 2008, hedge funds went through significant regulatory and risk management changes. Now, most hedge funds are required to be registered. There’s also a big emphasis on due diligence and transparency. The introduction of UMR, which stands for uncleared margin rules, has increased the focus on collateral management practices. Initial margin is almost entirely value-at-risk (VaR) stress-test-based these days, and, overall, margin optimisation is playing quite a significant role in the trading decision-making process